Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals, Inc. - Common Stock (NQ:AGIO)

35.65 +6.04 (+20.40%)
Streaming Delayed Price Updated: 12:39 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,939,561
Open 33.72
Bid (Size) 35.61 (100)
Ask (Size) 35.69 (200)
Prev. Close 29.61
Today's Range 33.67 - 36.35
52wk Range 22.24 - 46.00
Shares Outstanding 58,951,469
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today ↗
The young drugmaker's sickle cell treatment is receiving special consideration from the United States' top drug regulator. 
Via The Motley Fool
News headline image
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything ↗
Focused on therapies for rare blood disorders, this biotech saw a notable insider sale amid ongoing clinical development efforts. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+31.2%
+31.2%
1 Month
+22.1%
+22.1%
3 Month
+31.3%
+31.3%
6 Month
-9.2%
-9.2%
1 Year
+21.7%
+21.7%

More News

Read More
News headline image
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer ↗
Via The Motley Fool
Agios Pharmaceuticals Inc (NASDAQ:AGIO) Reports Q4 2025 Revenue Beat and Narrower Loss ↗
Via Chartmill
Agios Pharmaceuticals Stock Suffers Record Wipeout As Wall Street Warns Of 'Uncertain' Regulatory Path For Sickle Cell Drug ↗
Via Stocktwits
News headline image
Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Agios (AGIO) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Retail’s Christmas Eve Watchlist: Omeros, Nike, Citi, Dynavax And Agios Spark Most Market Chatter ↗
Via Stocktwits
Topics ETFs Economy Stocks
News headline image
Here's Why Shares in Agios Pharmaceuticals Popped Today ↗
Via The Motley Fool
News headline image
Which stocks are gapping on Wednesday? ↗
Via Chartmill
News headline image
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
Via PredictStreet
Topics Economy
News headline image
Why Did AGIO Stock Surge 14% Today? ↗
Via Stocktwits
News headline image
Nasdaq, S&P 500 Futures Head Into Christmas Eve With Caution: Why ASTS, DVAX, ABVX, PATH, GOOGL Are On Traders' Radar Today ↗
Via Stocktwits
Topics ETFs Stocks
News headline image
This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
Via Benzinga
News headline image
This Bellring Brands Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday ↗
Via Benzinga
News headline image
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
Agios Pharmaceuticals Plunges Over 50% as Sickle Cell Drug Delivers Mixed Phase 3 Results
Via MarketMinute
News headline image
Which stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
Why Shares in Agios Pharmaceuticals Got Crushed Today ↗
Via The Motley Fool
News headline image
Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results ↗
Via Benzinga
News headline image
Why Is Agios Pharmaceuticals Stock Sinking Today? ↗
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial ↗
Via Stocktwits

Frequently Asked Questions

Is Agios Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Agios Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Agios Pharmaceuticals, Inc. - Common Stock trade on?
Agios Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Agios Pharmaceuticals, Inc. - Common Stock is AGIO on the Nasdaq Stock Market
What is the current price of Agios Pharmaceuticals, Inc. - Common Stock?
The current price of Agios Pharmaceuticals, Inc. - Common Stock is 35.65
When was Agios Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Agios Pharmaceuticals, Inc. - Common Stock was at 03/31/26 12:39 PM ET
What is the market capitalization of Agios Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Agios Pharmaceuticals, Inc. - Common Stock is 2.10B
How many shares of Agios Pharmaceuticals, Inc. - Common Stock are outstanding?
Agios Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS